Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro
- PMID: 10896252
Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro
Abstract
TFPI is a potent inhibitor of the extrinsic coagulation system constitutively synthesized by endothelial cells. A major portion of intravascular TFPI is stored associated with endothelial cells. and administration of unfractionated heparin (UFH) in vivo causes a prompt mobilization of TFPI into the circulation. The present study was conducted to investigate how UFH affected the synthesis, secretion and anticoagulant potency of TFPI in endothelial cells in vitro. A spontaneously transformed immortal endothelial cell line was used (ECV304). Stimulation of ECV304 cells with UFH caused a prompt dose-dependent (0-5 IU UFH/ml) release of TFPI to the medium accompanied by no change of TFPI at the surface membrane assessed by immunocytochemical methods. Northern blot analysis revealed two mRNA transcripts for TFPI with a molecular size of 1.4 kb and 4.4 kb, respectively. Stimulation of ECV304 cells for 24 hrs with various concentrations of UFH caused a dose-dependent increase of TFPI in the medium (6.2-29.6 ng/10(6) cells within the concentration range 0-10 IU/ml). A similar dose-dependent increase in the expression of both TFPI mRNA species was observed. Long-term incubation of ECV304 cells with 5.0 IU/ml UFH caused a 5-10 fold increase in the TFPI concentration accumulated in the medium over 48 hrs. The increased TFPI mRNA expression induced by UFH appeared already after 10 min, peaked after 2-4 hrs, remained augmented throughout the entire period of UFH exposure, and preceded the synthesis-dependent increase in TFPI release by 2-4 hrs. The procoagulant activity of the cells was downregulated by 36% and the contribution of TFPI to the anticoagulant potency of ECV304 cells was moderately increased after 24 hrs heparin stimulation. It is suggested that these mechanisms are of major importance for the anticoagulant function of heparins.
Similar articles
-
Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro.Thromb Haemost. 2001 Dec;86(6):1547-54. Thromb Haemost. 2001. PMID: 11776326
-
Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.J Lab Clin Med. 2006 Apr;147(4):167-73. doi: 10.1016/j.lab.2005.11.010. J Lab Clin Med. 2006. PMID: 16581344
-
Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.J Lab Clin Med. 2004 Nov;144(5):246-53; discussion 226-7. doi: 10.1016/j.lab.2004.08.001. J Lab Clin Med. 2004. PMID: 15570242 Clinical Trial.
-
The role of tissue factor pathway inhibitor in tumor growth and metastasis.Semin Thromb Hemost. 2007 Oct;33(7):643-52. doi: 10.1055/s-2007-991531. Semin Thromb Hemost. 2007. PMID: 18000790 Review.
-
Heparanase, tissue factor, and cancer.Semin Thromb Hemost. 2008 Mar;34(2):187-94. doi: 10.1055/s-2008-1079259. Semin Thromb Hemost. 2008. PMID: 18645924 Review.
Cited by
-
Targeting TFPI for hemophilia treatment.Thromb Res. 2016 May;141 Suppl 2(Suppl 2):S28-30. doi: 10.1016/S0049-3848(16)30359-0. Thromb Res. 2016. PMID: 27207418 Free PMC article. Review.
-
Overexpression of glutathione S-transferase A1-1 in ECV 304 cells protects against busulfan mediated G2-arrest and induces tissue factor expression.Br J Pharmacol. 2002 Dec;137(7):1100-6. doi: 10.1038/sj.bjp.0704972. Br J Pharmacol. 2002. PMID: 12429583 Free PMC article.
-
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.J Thromb Thrombolysis. 2002 Oct;14(2):123-9. doi: 10.1023/a:1023280811804. J Thromb Thrombolysis. 2002. PMID: 12714831
-
New insights into the biology of tissue factor pathway inhibitor.J Thromb Haemost. 2015 Jun;13 Suppl 1(0 1):S200-7. doi: 10.1111/jth.12897. J Thromb Haemost. 2015. PMID: 26149025 Free PMC article. Review.
-
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor.J Thromb Thrombolysis. 2003 Feb;15(1):19-23. doi: 10.1023/a:1026136216869. J Thromb Thrombolysis. 2003. PMID: 14574072
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous